Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival.

The present study determined whether AMP-activated protein kinase (AMPK) regulates heme oxygenase (HO)-1 gene expression in endothelial cells (ECs) and if HO-1 contributes to the biological actions of this kinase. Treatment of human ECs with the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) stimulated a concentration- and time-dependent increase in HO-1 protein and mRNA expression that was associated with a prominent increase in nuclear factor-erythroid 2-related factor 2 (Nrf2) protein. Induction of HO-1 was also observed in rat carotid arteries after the in vivo application of AICAR. Induction of HO-1 by AICAR was blocked by the AMPK inhibitor compound C, the adenosine kinase inhibitor 5'-iodotubercidin, and by silencing AMPK-α(1/2) and was mimicked by the AMPK activator A-769662 and by infecting ECs with an adenovirus expressing constitutively active AMPK-α(1). AICAR also induced a significant rise in HO-1 promoter activity that was abolished by mutating the antioxidant responsive elements of the HO-1 promoter or by the overexpression of dominant negative Nrf2. Finally, activation of AMPK inhibited cytokine-mediated EC death, and this was prevented by the HO inhibitor tin protoporphyrin-IX or by silencing HO-1 expression. In conclusion, AMPK stimulates HO-1 gene expression in human ECs via the Nrf2/antioxidant responsive element signaling pathway. The induction of HO-1 mediates the antiapoptotic effect of AMPK, and this may provide an important adaptive response to preserve EC viability during periods of metabolic stress.

[1]  Jae Heun Lee,et al.  Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells. , 2009, Atherosclerosis.

[2]  Donna D. Zhang,et al.  Phosphorylation of Nrf2 at Multiple Sites by MAP Kinases Has a Limited Contribution in Modulating the Nrf2-Dependent Antioxidant Response , 2009, PloS one.

[3]  B. Fisslthaler,et al.  Activation and signaling by the AMP-activated protein kinase in endothelial cells. , 2009, Circulation research.

[4]  S. Moncada,et al.  AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. , 2009, The Biochemical journal.

[5]  J. Coselli,et al.  Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin , 2009, Diabetes.

[6]  S. Ryter,et al.  Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. , 2009, Free radical biology & medicine.

[7]  B. Viollet,et al.  In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I , 2009, Diabetes.

[8]  G. Zhou,et al.  AMPK activators – potential therapeutics for metabolic and other diseases , 2009, Acta physiologica.

[9]  W. Durante,et al.  Arginase Promotes Neointima Formation in Rat Injured Carotid Arteries , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Tsai,et al.  AMP-Activated Protein Kinase Functionally Phosphorylates Endothelial Nitric Oxide Synthase Ser633 , 2009, Circulation research.

[11]  R. Nagai,et al.  A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell , 2009, Hypertension Research.

[12]  G. Gross,et al.  AICAR Preconditioning Prevents Postischemic Leukocyte Rolling and Adhesion: Role of KATP Channels and Heme Oxygenase , 2008, Microcirculation.

[13]  I. Salt,et al.  Inhibition of Tumor Necrosis Factor &agr;–Stimulated Monocyte Adhesion to Human Aortic Endothelial Cells by AMP-Activated Protein Kinase , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[14]  B. Viollet,et al.  Upregulation of Mitochondrial Uncoupling Protein-2 by the AMP-Activated Protein Kinase in Endothelial Cells Attenuates Oxidative Stress in Diabetes , 2008, Diabetes.

[15]  J. Keaney,et al.  Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction , 2008, Circulation.

[16]  B. Viollet,et al.  Role of AMP-activated protein kinase in autophagy and proteasome function. , 2008, Biochemical and biophysical research communications.

[17]  M. Zou,et al.  AMP‐ACTIVATED PROTEIN KINASE ACTIVATION AS A STRATEGY FOR PROTECTING VASCULAR ENDOTHELIAL FUNCTION , 2008, Clinical and experimental pharmacology & physiology.

[18]  Wu-chang Yang,et al.  Far Infrared Therapy Inhibits Vascular Endothelial Inflammation via the Induction of Heme Oxygenase-1 , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[19]  B. Viollet,et al.  Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[20]  Hong Wang,et al.  Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. , 2007, Cardiovascular research.

[21]  G. Siegal,et al.  Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism , 2007, The Journal of experimental medicine.

[22]  J. Cook,et al.  How many transcription factors does it take to turn on the heme oxygenase-1 gene? , 2007, American journal of respiratory cell and molecular biology.

[23]  F. Gaskin,et al.  5′‐AMP‐activated protein kinase activation prevents postischemic leukocyte‐endothelial cell adhesive interactions: Role of nitric oxide , 2006, American journal of physiology. Heart and circulatory physiology.

[24]  D. Pipeleers,et al.  Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation. , 2007, Free radical biology & medicine.

[25]  W. Durante,et al.  Role of carbon monxide in cardiovascular function , 2006, Journal of cellular and molecular medicine.

[26]  Kunihiro Suzuki,et al.  Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells , 2006, Hypertension.

[27]  B. Viollet,et al.  Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. , 2006, Diabetes.

[28]  E. Araki,et al.  Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. , 2006, Diabetes.

[29]  R. Takeda,et al.  AMP-Activated Protein Kinase Inhibits Angiotensin II– Stimulated Vascular Smooth Muscle Cell Proliferation , 2004, Circulation.

[30]  J. Connell,et al.  Direct Activation of AMP-activated Protein Kinase Stimulates Nitric-oxide Synthesis in Human Aortic Endothelial Cells* , 2003, Journal of Biological Chemistry.

[31]  K. Walsh,et al.  AMP-activated Protein Kinase (AMPK) Signaling in Endothelial Cells Is Essential for Angiogenesis in Response to Hypoxic Stress* , 2003, Journal of Biological Chemistry.

[32]  J. Alam,et al.  Degradation of Transcription Factor Nrf2 via the Ubiquitin-Proteasome Pathway and Stabilization by Cadmium* , 2003, The Journal of Biological Chemistry.

[33]  D J Campbell,et al.  AMP-activated protein kinase, super metabolic regulator. , 2001, Biochemical Society transactions.

[34]  O. Pedersen,et al.  Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. , 2002, Diabetes.

[35]  W. Durante,et al.  Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. , 2002, Blood.

[36]  D. Carling,et al.  Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. , 2002, Diabetes.

[37]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[38]  A. Choi,et al.  Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis , 2000, The Journal of experimental medicine.

[39]  J. Pober,et al.  Cytoprotection of Human Umbilical Vein Endothelial Cells Against Apoptosis and CTL-Mediated Lysis Provided by Caspase-Resistant Bcl-2 Without Alterations in Growth or Activation Responses1 , 2000, The Journal of Immunology.

[40]  W. O'Brien,et al.  Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium. , 1996, Circulation research.

[41]  S. Hawley,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[42]  D. Hardie,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[43]  D. Simard,et al.  Timely administration of AICA riboside reduces reperfusion injury in rabbits. , 1994, Cardiovascular research.

[44]  A. Paterson,et al.  Inhibitors of nucleoside and nucleotide metabolism. , 1972, Cancer chemotherapy reports. Part 2.